Final answer:
Patients switching to injectable aripiprazole are usually bridged with oral therapy for 14 days before fully transitioning. Dosage and timing may be adjusted during this period. Close communication with healthcare provider is important.
Step-by-step explanation:
The duration of bridging with oral therapy for patients switching to injectable aripiprazole depends on various factors such as the individual patient's condition and response to treatment. Generally, patients are bridged with oral therapy for 14 days before transitioning to injectable aripiprazole. This helps ensure a smooth transition and minimize any potential discontinuation symptoms or therapeutic gaps.
During this bridging period, patients typically continue taking their oral aripiprazole while the injectable form is slowly introduced. The dosage and timing of the oral medication may be adjusted based on the healthcare provider's recommendation and the patient's specific needs.
It is important for patients to follow their healthcare provider's instructions closely and communicate any concerns or difficulties during the transition period. This will help ensure the safe and effective use of injectable aripiprazole.